Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.

MLA

Hovd, Markus, et al. “Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.” Clinical Pharmacokinetics, vol. 62, no. 5, May 2023, pp. 725–35. EBSCOhost, https://doi.org/10.1007/s40262-023-01235-5.

APA

Hovd, M., Robertsen, I., Johnson, L. K., Krogstad, V., Wegler, C., Kvitne, K. E., Kringen, M. K., Skovlund, E., Karlsson, C., Andersson, S., Artursson, P., Sandbu, R., Hjelmesæth, J., Åsberg, A., Jansson-Löfmark, R., & Christensen, H. (2023). Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance. Clinical Pharmacokinetics, 62(5), 725–735. https://doi.org/10.1007/s40262-023-01235-5

Chicago

Hovd, Markus, Ida Robertsen, Line Kristin Johnson, Veronica Krogstad, Christine Wegler, Kine Eide Kvitne, Marianne Kristiansen Kringen, et al. 2023. “Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.” Clinical Pharmacokinetics 62 (5): 725–35. doi:10.1007/s40262-023-01235-5.